Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Clinical Performance Evaluation of the In-Vitro Diagnostics Medical Device MaGIA IBC for the CombIned screENing of HIV, Hepatitis B and Hepatitis C

NCT06082336 is registered in ClinicalTrials.gov with MagIA Diagnostics as lead sponsor.

NCT NCT06082336
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06082336 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Clinical Performance Evaluation of the In-Vitro Diagnostics Medical Device MaGIA IBC for the CombIned screENing of HIV, Hepatitis B and Hepatitis C
Lead sponsor
MagIA Diagnostics
Phase
Not applicable
Overall status
Terminated
Start date
September 16, 2024
Completion date
March 24, 2026
Enrollment
96 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

combined point of care diagnostic of hiv, hbv and hcv